Summary & Overview
HCPCS G0012: Injection of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention
HCPCS Level II code G0012 denotes the administration of an injectable pre-exposure prophylaxis (PrEP) medication for HIV prevention, given subcutaneously or intramuscularly. This code matters nationally as long-acting injectable PrEP expands clinical options for HIV prevention, affecting coverage determinations, billing workflows, and access in outpatient and ambulatory settings. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will gain a concise account of what G0012 represents clinically and operationally, plus an outline of payer coverage patterns and billing considerations relevant to ambulatory medication administration. The publication summarizes benchmarks where available, highlights recent policy updates influencing coverage of long-acting injectable PrEP, and provides clinical context about the service type and typical sites of service. Practical billing elements covered include the code’s intended use, common modifiers in payer practice (listed separately), and areas where payers commonly require documentation or prior authorization.
Intended for providers, billing professionals, and policy analysts, this summary helps stakeholders understand where G0012 fits into HIV prevention services nationally and what to expect in payer interactions and billing workflows.
Billing Code Overview
HCPCS Level II code G0012 describes the injection of a pre-exposure prophylaxis (PrEP) drug for HIV prevention, administered subcutaneously (under the skin) or intramuscularly (into the muscle). This service represents the single administration of a long-acting or injectable PrEP agent intended to reduce the risk of HIV acquisition in individuals at substantial risk.
Service Type: Medication administration (injectable), preventive intervention
Typical Site of Service: Outpatient clinic, physician office, community health center, or other ambulatory setting where injectable preventive medications are administered
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A sexually active adult patient at increased risk for HIV presents to an outpatient clinic for initiation or continuation of long-acting injectable pre-exposure prophylaxis. The clinical workflow includes eligibility assessment (HIV testing, renal function, hepatitis screening), patient counseling on adherence and safer sex practices, confirmation of negative HIV status on the day of injection, and administration of the intramuscular injection. The injection is administered under the skin or into muscle in a clinic procedure room, urgent care, community health center, or designated injection suite. Observation for a short period post-injection for immediate adverse reactions is typical. Documentation includes the G0012 service, drug name and NDC, lot number, injection site, route, patient consent, and relevant labs and screening results in the medical record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no modifier applies and services delivered as billed |
22 | Increased procedural services |